Last Posted: Jan 18, 2019
- Response to the Commentary: Precision Health: Using Omics to Optimize Self-Management of Chronic Pain in Aging: From the Perspective of the NINR Intramural Research Program.
Cashion Ann K et al. Research in gerontological nursing 2018 11(1) 14-15 - Genetic testing is the future of healthcare, but many experts say companies like 23andMe are doing more harm than good
E Brodwin, Business Insider, January 7, 2019 - A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
Porter Tenielle et al. Frontiers in aging neuroscience 2018 10423 - Exceptional Human Longevity.
Pignolo Robert J et al. Mayo Clinic proceedings 2018 Dec - Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.
Ryden Lauren E et al. Drugs & aging 2018 Dec - Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy?
Ibraheem Abiola F et al. Cancer 2018 Nov - The Key to a Long Life Has Little to Do With ‘Good Genes’
M Molteni, WIRED November 6, 2018 - Recent Advances in Biomarkers for Parkinson's Disease.
He Runcheng et al. Frontiers in aging neuroscience 2018 10305 - Alzheimer's Disease and Healthy Aging
CDC Information, 2018 - Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers.
Sapkota Shraddha et al. Frontiers in aging neuroscience 2018 10296
.png)
No hay comentarios:
Publicar un comentario